giovannelli-associati-logogiovannelli-associati-logo-stickygalaw-giovannelli-e-associati-logo-mobile-centro-130×35giovannelli-associati-logo
  • HOME
  • OUR FIRM
    • About us
    • International strategy
  • TEAM
    • Partners
    • Of Counsel
    • Associates
  • PRACTICE AREAS
    • Mergers and Acquisitions – Private Equity
    • Finance & Restructuring
    • Capital Markets
    • Corporate and Commercial matters
    • Intellectual Property
    • Labour Law
    • Litigation and Arbitration
    • Privacy
    • Tax
  • MEDIA
  • WORK WITH US
  • CONTACTS
English
  • Italian
✕
Legalcommunity Finance Awards 2022: Valerio Fontanesi of Giovannelli e Associati awarded for the category Thought leadership
07/03/2022
Giovannelli e Associati with WindeX Investment Club on the acquisition of Messersi Spa
21/03/2022
Mostra tutto

Giovannelli e Associati advised Neopharmed Gentili on their acquisition of lormetazepam product portfolio

Pubblicato da Giovannelli e Associati il 07/03/2022

Neopharmed Gentili, a pharmaceutical company specialized in the marketing of high therapeutic value solutions controlled by Ardian together with the Del Bono family, has entered into an agreement with Bayer for the acquisition of rights in Italy and Japan of the historical brands Minias and Noctamid (Italy) and Evamyl (Japan), which are products used in the short-term treatment of insomnia, in particular anxiety-induced insomnia.

Giovannelli e Associati assisted Neopharmed Gentili in all legal aspects of the transaction with a team led by partner Fabrizio Scaparro and comprising senior associate Laura Bernardi,  associate Paola Pagani and trainee Camilla Lanzafame for corporate and commercial matters, partner Riccardo Pontremoli trainee Carlo Pilia for the administrative/regulatory matters and partner Alessandra Feller with associate Ginevra Lombardi for the IP matters.

Neopharmed Gentili was assisted by Loeschner Rechtsanwaltsgesellschaft mbH for the German law aspects of the transaction with the partner Ramin Loeschner and Vasco da Gama law firm for the Japanese law aspects of the transaction with a team led by the partner Peter Tam assisted by the associate Yuko Kaneko.

Read More:

Neopharmed Gentili – Bayer – LC – 03.03.2022
Neopharmed Gentili – Bayer – NT24 – 04.03.2022
Neopharmed Gentili – Bayer – GLC – 03.03.2022
Condividi

Media correlati

10/08/2022

Giovannelli e Associati advised Neopharmed Gentili on the acquisition of the entire share capital of Valeas


Leggi tutto
29/07/2022

Giovannelli e Associati with Neva SGR on the investment round of Casavo


Leggi tutto
20/07/2022

Giovannelli e Associati with Blacksheep Madtech Fund on the investment round of iGenius


Leggi tutto

Cerca news e media

✕

Latest News&Media

  • Giovannelli e Associati advised Neopharmed Gentili on the acquisition of the entire share capital of Valeas
    10/08/2022
  • Giovannelli e Associati with Neva SGR on the investment round of Casavo
    29/07/2022
  • Giovannelli e Associati with Blacksheep Madtech Fund on the investment round of iGenius
    20/07/2022

Categories

  • Articles
  • Giovannelli e Associati @en
  • HOT TOPICS: LABOUR
  • HOT TOPICS: TAX
  • News
  • Press Release

Pratice Areas

  • Mergers and Acquisitions – Private Equity
  • Finance & Restructuring
  • Capital Markets
  • Corporate and Commercial matters
  • Intellectual Property
  • Labour Law
  • Litigation and Arbitration
  • Privacy
  • Tax
© Copyright 2021 Giovannelli e Associati | Via dei Bossi, 4 20121 Milano, Italia | P.IVA 08347040969 | Note Legali | Privacy Policy | Credits